|
WWC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.782000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.208200E-02 |
| Normal-vs-Stage2 |
3.019600E-01 |
| Normal-vs-Stage3 |
5.399500E-02 |
| Normal-vs-Stage4 |
6.640500E-02 |
| Stage1-vs-Stage2 |
3.129700E-02 |
| Stage1-vs-Stage3 |
9.016200E-01 |
| Stage1-vs-Stage4 |
7.767800E-01 |
| Stage2-vs-Stage3 |
3.207600E-02 |
| Stage2-vs-Stage4 |
3.377900E-02 |
| Stage3-vs-Stage4 |
8.537000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.333900E-02 |
| Normal-vs-AfricanAmerican |
3.910000E-01 |
| Normal-vs-Asian |
5.801500E-02 |
| Caucasian-vs-AfricanAmerican |
7.713200E-01 |
| Caucasian-vs-Asian |
6.254200E-01 |
| AfricanAmerican-vs-Asian |
5.147000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.189200E-01 |
| Normal-vs-Female |
7.768100E-02 |
| Male-vs-Female |
4.974200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.457700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.055610E-01 |
| Normal-vs-Age(61-80Yrs) |
5.069000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.594000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.439000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.797800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.140400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.688600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.709600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.788000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.702800E-01 |
| Classical-VS-Follicular |
4.141000E-01 |
| Classical-VS-Other |
5.798800E-01 |
| Classical-VS-Normal |
6.937900E-02 |
| Tall-VS-Follicular |
7.538600E-01 |
| Tall-VS-Other |
6.406400E-01 |
| Tall-VS-Normal |
3.205000E-01 |
| Follicular-VS-Other |
6.969000E-01 |
| Follicular-VS-Normal |
4.899200E-01 |
| Other-VS-Normal |
8.204200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.083600E-01 |
| Normal-vs-N1 |
6.001100E-03 |
| N0-vs-N1 |
7.201900E-02 |
|
|
